BioLineRx to Report 2025 Annual Results on March 23, 2026
Go back to BioLineRx to Report 2025 Annual Results on March 23, 2026| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.80 +0.10 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $1.63 | |||
| Open | $2.73 | 52 Week Low | $0.71 | |||
| Day High | $2.81 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $0.00 | |||
| Volume | 8,504 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.80 +0.10 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $1.63 | |||
| Open | $2.73 | 52 Week Low | $0.71 | |||
| Day High | $2.81 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $0.00 | |||
| Volume | 8,504 | |||||

